Vanguard Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$215M Sell
5,831,311
-36,148
-0.6% -$1.33M ﹤0.01% 1473
2025
Q1
$230M Buy
5,867,459
+60,276
+1% +$2.37M ﹤0.01% 1418
2024
Q4
$270M Buy
5,807,183
+189,791
+3% +$8.82M ﹤0.01% 1393
2024
Q3
$254M Buy
5,617,392
+25,101
+0.4% +$1.13M ﹤0.01% 1419
2024
Q2
$276M Buy
5,592,291
+130,059
+2% +$6.41M 0.01% 1315
2024
Q1
$187M Sell
5,462,232
-13,090
-0.2% -$449K ﹤0.01% 1563
2023
Q4
$202M Sell
5,475,322
-115,652
-2% -$4.26M ﹤0.01% 1500
2023
Q3
$113M Sell
5,590,974
-292,411
-5% -$5.92M ﹤0.01% 1737
2023
Q2
$120M Buy
5,883,385
+185,038
+3% +$3.79M ﹤0.01% 1748
2023
Q1
$85.9M Buy
5,698,347
+469,002
+9% +$7.07M ﹤0.01% 1896
2022
Q4
$125M Buy
5,229,345
+310,380
+6% +$7.39M ﹤0.01% 1687
2022
Q3
$173M Sell
4,918,965
-13,562
-0.3% -$478K 0.01% 1468
2022
Q2
$172M Buy
4,932,527
+141,453
+3% +$4.95M ﹤0.01% 1521
2022
Q1
$237M Buy
4,791,074
+467,466
+11% +$23.1M 0.01% 1444
2021
Q4
$335M Buy
4,323,608
+35,010
+0.8% +$2.71M 0.01% 1261
2021
Q3
$459M Buy
4,288,598
+108,938
+3% +$11.7M 0.01% 1026
2021
Q2
$557M Buy
4,179,660
+220,331
+6% +$29.4M 0.01% 927
2021
Q1
$490M Buy
3,959,329
+435,943
+12% +$54M 0.01% 962
2020
Q4
$498M Buy
3,523,386
+1,140,123
+48% +$161M 0.01% 880
2020
Q3
$181M Buy
2,383,263
+724,962
+44% +$55.1M 0.01% 1342
2020
Q2
$75.1M Buy
1,658,301
+155,845
+10% +$7.06M ﹤0.01% 1804
2020
Q1
$45.9M Buy
1,502,456
+400,529
+36% +$12.2M ﹤0.01% 1904
2019
Q4
$23.1M Buy
1,101,927
+8,245
+0.8% +$173K ﹤0.01% 2460
2019
Q3
$26.1M Buy
1,093,682
+38,208
+4% +$912K ﹤0.01% 2351
2019
Q2
$30.6M Buy
1,055,474
+805,251
+322% +$23.4M ﹤0.01% 2332
2019
Q1
$5.8M Buy
250,223
+41,766
+20% +$968K ﹤0.01% 3086
2018
Q4
$4.81M Buy
+208,457
New +$4.81M ﹤0.01% 3105